Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

54.45
Delayed Data
As of Apr 29
 -0.54 / -0.98%
Today’s Change
52.62
Today|||52-Week Range
72.31
-17.05%
Year-to-Date

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of 74.00, with a high estimate of 100.00 and a low estimate of 61.00. The median estimate represents a +35.90% increase from the last price of 54.45.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Buy stock in Teva Pharmaceutical. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.17
Sales
$4.8B
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.52%
 
 
 
 
 
 
Growthannually 5.53%
 
 
 
 
 
 

Sales

Growthquarterly -1.38%
 
 
 
 
 
 
Growthannually 21.62%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.